ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $109 | -99.9% | 24,800 | -81.3% | 0.01% | -35.7% |
| Q3 2022 | $192,000 | -27.3% | 132,346 | +9.0% | 0.01% | -26.3% |
| Q2 2022 | $264,000 | +234.2% | 121,400 | +184.3% | 0.02% | +375.0% |
| Q1 2022 | $79,000 | -6.0% | 42,700 | +221.3% | 0.00% | +33.3% |
| Q4 2021 | $84,000 | +223.1% | 13,291 | -16.9% | 0.00% | +200.0% |
| Q3 2021 | $26,000 | -76.1% | 15,990 | -6.5% | 0.00% | -80.0% |
| Q2 2021 | $109,000 | +75.8% | 17,100 | +235.3% | 0.01% | +66.7% |
| Q1 2021 | $62,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
| Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
| Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
| Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
| ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
| Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |